ARCHIVES

FDA Advisors Oppose Group’s Tamoxifen Trial, But Okay The Idea

This article is from The Cancer Letter archive.

Vol. 16 No. 27 | July 6, 1990

Download PDF Visit The Full Archive

Related Articles

New Patterns Of Care Study Okayed By DCT Board

June 13, 1986

FDA Advisors Recommend Approval Of Taxol for Node-Positive Breast Cancer

September 24, 1999

In Brief: Transition Team Denies It Is Seeking New NCI Director; Garb Undergoes Surgery At M.D.A

November 28, 1980

NCI Committed To 50 Percent Mortality Reduction By 2000; DCPC Board Hears How That Will Be Done

January 20, 1984

Broder Responds To AACR Proposal, Cites Congressional ‘Commitment’

December 6, 1991

In Brief: General Motors Cancer Prizes Awarded; Thomas Promoted; HIV Research funding

June 24, 1994